Another successful year
Released on : Jan. 08, 2024
Tri-Med is pleased to announce to completion of another successful year of no adverse events for PYtest, CLOtest and our MCL instrument, reported locally. Since PYtest’s inception and entry into the market, there have been no confirmed adverse events. This is a testament to the PYtest inventor and Nobel Laureate recipient, Professor Barry Marshall, and the Tri-Med team for ensuring the consistent quality of all products manufactured and distributed.
As Tri-Med enters into its 28th year of operation we are looking forward to continue servicing the market with PYtest, CLOtest and our MCL instrument in order to continue to facilitate our purpose in the detection and treatment of Helicobacter pylori globally.
#hpylori#helicobacter#nobel#laureate#trimed#success